Zydus Lifesciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
For the full year, revenue was INR 198,315 million compared to INR 174,240 million a year ago. Net income was INR 38,595 million compared to INR 19,603 million a year ago. Basic earnings per share from continuing operations was INR 37.91 compared to INR 19.35 a year ago. Diluted earnings per share from continuing operations was INR 37.91 compared to INR 19.35 a year ago. Basic earnings per share was INR 38.14 compared to INR 19.3 a year ago. Diluted earnings per share was INR 38.14 compared to INR 19.3 a year ago.